Nicholas Investment Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,587
| Closed | -$804K | – | 228 |
|
|
2024
Q4 | $804K | Sell |
5,587
-38,195
| -87% | -$5.48M | 0.07% | 194 |
|
|
2024
Q3 | $6.52M | Buy |
+43,782
| New | +$6.28M | 0.6% | 54 |
|
|
2023
Q1 | – | Sell |
-87,487
| Closed | -$14.8M | – | 213 |
|
|
2022
Q4 | $14.8M | Sell |
87,487
-235
| -0.3% | -$42.6K | 1.3% | 24 |
|
|
2022
Q3 | $16.4M | Sell |
87,722
-24,057
| -22% | -$5.07M | 1.52% | 13 |
|
|
2022
Q2 | $18.2M | Sell |
111,779
-5,208
| -4% | -$824K | 1.72% | 10 |
|
|
2022
Q1 | $22M | Buy |
116,987
+19,235
| +20% | +$3.65M | 1.57% | 11 |
|
|
2021
Q4 | $25.9M | Buy |
97,752
+9,131
| +10% | +$2.46M | 1.64% | 7 |
|
|
2021
Q3 | $25.6M | Sell |
88,621
-48,031
| -35% | -$12.3M | 1.87% | 5 |
|
|
2021
Q2 | $27.3M | Sell |
136,652
-5,451
| -4% | -$1.06M | 1.71% | 3 |
|
|
2021
Q1 | $27.6M | Buy |
142,103
+11,612
| +9% | +$2.38M | 1.93% | 3 |
|
|
2020
Q4 | $25M | Buy |
130,491
+290
| +0.2% | +$52.8K | 1.93% | 5 |
|
|
2020
Q3 | $19.2M | Buy |
130,201
+99,540
| +325% | +$14.2M | 2.08% | 7 |
|
|
2020
Q2 | $3.79M | Sell |
30,661
-37,461
| -55% | -$4.41M | 0.77% | 38 |
|
|
2020
Q1 | $6.58M | Sell |
68,122
-9,328
| -12% | -$901K | 1.28% | 14 |
|
|
2019
Q4 | $7.16M | Sell |
77,450
-57,454
| -43% | -$4.83M | 0.74% | 28 |
|
|
2019
Q3 | $10.3M | Buy |
134,904
+78,484
| +139% | +$6.86M | 0.87% | 25 |
|
|
2019
Q2 | $4.85M | Sell |
56,420
-322
| -0.6% | -$21.9K | 0.44% | 78 |
|
|
2019
Q1 | $3.35M | Sell |
56,742
-9,889
| -15% | -$569K | 0.3% | 113 |
|
|
2018
Q4 | $3.51M | Sell |
66,631
-336
| -0.5% | -$19.7K | 0.38% | 94 |
|
|
2018
Q3 | $3.71M | Sell |
66,967
-24,386
| -27% | -$1.26M | 0.3% | 135 |
|
|
2018
Q2 | $4.3M | Buy |
91,353
+6,599
| +8% | +$272K | 0.3% | 103 |
|
|
2018
Q1 | $3.07M | Buy |
84,754
+30,230
| +55% | +$1.06M | 0.22% | 152 |
|
|
2017
Q4 | $1.98M | Sell |
54,524
-25,249
| -32% | -$914K | 0.13% | 209 |
|
|
2017
Q3 | $3.06M | Buy |
79,773
+123
| +0.2% | +$5.16K | 0.21% | 165 |
|
|
2017
Q2 | $3.3M | Buy |
79,650
+359
| +0.5% | +$13.6K | 0.23% | 155 |
|
|
2017
Q1 | $2.79M | Sell |
79,291
-20,701
| -21% | -$656K | 0.2% | 183 |
|
|
2016
Q4 | $3.08M | Sell |
99,992
-32,016
| -24% | -$990K | 0.23% | 180 |
|
|
2016
Q3 | $3.98M | Hold |
132,008
| – | – | 0.26% | 143 |
|
|
2016
Q2 | $3.61M | Buy |
132,008
+41,793
| +46% | +$1.07M | 0.25% | 171 |
|
|
2016
Q1 | $2.42M | Sell |
90,215
-30,048
| -25% | -$735K | 0.18% | 216 |
|
|
2015
Q4 | $3.4M | Buy |
120,263
+50,629
| +73% | +$1.46M | 0.24% | 179 |
|
|
2015
Q3 | $1.94M | Buy |
69,634
+5,552
| +9% | +$201K | 0.14% | 246 |
|
|
2015
Q2 | $2.65M | Sell |
64,082
-20,543
| -24% | -$753K | 0.17% | 230 |
|
|
2015
Q1 | $2.57M | Sell |
84,625
-124,296
| -59% | -$3.22M | 0.16% | 229 |
|
|
2014
Q4 | $4.14M | Buy |
208,921
+401
| +0.2% | +$8.96K | 0.26% | 161 |
|
|
2014
Q3 | $4.15M | Buy |
208,520
+12,150
| +6% | +$256K | 0.26% | 124 |
|
|
2014
Q2 | $4.47M | Sell |
196,370
-9,472
| -5% | -$169K | 0.26% | 118 |
|
|
2014
Q1 | $2.65M | Sell |
205,842
-49,445
| -19% | -$709K | 0.22% | 161 |
|
|
2013
Q4 | $3.48M | Sell |
255,287
-7,755
| -3% | -$92.6K | 0.27% | 89 |
|
|
2013
Q3 | $2.92M | Buy |
263,042
+9,526
| +4% | +$94.8K | 0.24% | 120 |
|
|
2013
Q2 | $2.09M | Buy |
+253,516
| New | +$2.13M | 0.19% | 168 |
|
Other funds holding RGEN
CIP
Nicholas Investment Partners's RGEN Position: Q1 2025 in Review
Nicholas Investment Partners sold out of Repligen (RGEN) in Q1 2025, closing a stake of 5,587 shares — an estimated $804K sold.
Nicholas Investment Partners first reported a position in RGEN in Q2 2013 and held it in 41 quarters. The position peaked at $27.6M in Q1 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Nicholas Investment Partners reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Nicholas Investment Partners sold 5,587 Repligen shares in Q1 2025, an estimated $804K.
- Nicholas Investment Partners first reported a position in Repligen in Q2 2013 and held it in 41 quarters.
- Nicholas Investment Partners's Repligen position peaked at $27.6M in Q1 2021.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Nicholas Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.